Getting ready for ARVO 2017: New president, special OCT issue
Learn about the latest updates from The Association for Research in Vision and Ophthalmology for 2017 and beyond.
Meet ARVO’s new president
Members of ARVO welcomed Emily Y. Chew, MD, FARVO, of the National Eye Institute/National Institutes of Health (NEI/NIH) as the association’s new president immediately following the ARVO 2016 Annual Meeting. Dr. Chew serves as the deputy director of the Division of Epidemiology and Clinical Applications, deputy clinical director, and the chief of the clinical trials branch at NEI/NIH.
Related:
“I am looking forward to ARVO leading the way in helping us unite our scientific communities and translate technical advances for meaningful and impactful clinical applications,” she said in the spring 2016 issue of ARVONews.
An ARVO member in the Clinical/Epidemiological Research (CL) Section since 1983, Dr. Chew has served as the CL Section of the Annual Meeting Program Committee, chair of the Awards Committee and a member of editorial board of ARVO’s Investigative Ophthalmology & Vision Science (IOVS) journal.
IOVS releases special issue on OCT
Did you know it has been 25 years since vision researchers developed the innovative OCT? To commemorate this milestone, ARVO has released a special issue of IOVS - publishing more than 70 papers from authors on five continents in the online-only, open access peer-review journal.
Related:
The OCT special issue, released in July, covers a wide range of topics of interest to clinicians, such as OCT technology and methods, cornea/anterior, retina, age-related macular degeneration, diabetic retinopathy, and glaucoma.
“It is now evident that OCT has transformed the practice of retina and glaucoma clinicians,” says OCT co-inventor and guest editor David Huang, MD, PhD, of Oregon Health and Science University. “This is also a time when two new exciting trends in OCT have taken off: OCT angiography and intraoperative OCT.”
Recent:
Anchoring the issue are seven invited review articles from pioneering research groups in their respective fields. Among those included are:
- “Clinical Utility of OCT in Glaucoma,” by researchers in the lab of Joel Schuman, MD, of New York University
- “Optical Coherence Tomography and the Development of Anti-Angiogenic Therapies in Neovascular Age-related Macular Degeneration,” by Philip J Rosenfeld, MD, PhD, at the University of Miami
- “Optical Coherence Tomography Angiography,” by researchers in the lab of David Huang, MD, PhD, OHSU
- “Optical coherence tomography for retinal surgery: perioperative analysis to real-time four-dimensional image-guided surgery,” by researchers in the labs of Joseph Izatt, PhD, and Cynthia Toth, MD, at Duke University
To read the IOVS special issue on OCT, visit